Earnings Ahead

NVAX - Novavax, Inc.

7.08 0.41 6.15

Novavax, Inc.

Novavax, Inc.

About

Profile

Novavax, Inc. is a clinical-stage vaccine company committed to delivering novel products to prevent a broad range of infectious diseases. Our recombinant nanoparticles and adjuvant technology are the foundation for groundbreaking innovation that improves


Headquarters

Rockville, Maryland, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

NVAX



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Novavax falls as Q4 results and 2024 outlook disappoint
  • SMXT, ANVS and IFBD among pre-market losers
  • Novavax GAAP EPS of -$1.44 misses by $0.99, revenue of $291M misses by $30.97M
  • ‘Tripledemic’ burden lower this winter despite COVID impact: Airfinity
  • Novavax Q4 2023 Earnings Preview
  • Novavax nears five-month high as COVID vaccine dispute ends
  • 5 stocks to watch on Thursday: Moderna, Enerplus on Chord Energy deal and more
  • Novavax settles COVID-19 vaccine dispute with Gavi
  • CDC to relax COVID isolation requirements: WaPo
  • Novavax-backed malaria vaccine shows 75% efficacy
  • Novavax to cut 12% of global workforce amid restructuring drive
  • Masking returns to some U.S. hospitals amid rising COVID, flu cases
  • Bank of America more favorable on SMID-cap biotechs into 2024
  • Novavax in 2024: What to expect?
  • JN.1 Omicron strain becomes dominant COVID variant in U.S.
  • Pfizer hits 52-week low, drags COVID vaccine peers on weak guidance
  • Canadian regulators authorize updated Novavax COVID-19 vaccine
  • Novavax settles class action lawsuit over COVID vaccine for $47M
  • Novavax's updated Covid-19 vaccine gets WHO emergency use listing
  • Pneumonia outbreak in China is no reason for alarm: WHO

Earnings History

Date EPS / Forecast Revenue / Forecast
November 4, 2021 -4.31 / -3.91 178.84M / 334.53M
August 5, 2021 -4.75 / -3.63 298.02M / 387.87M
May 10, 2021 -3.05 / -3.6 447.23M / 233.9M Beat!
March 1, 2021 -2.7 / -2.23 279.66M / 202.44M Beat!
November 9, 2020 -3.21 / 1.73 157.02M / 230.56M
August 10, 2020 -0.3 / -0.51 35.54M / 28.2M Beat!
May 11, 2020 -0.58 / -0.69 3.38M / 1.93M Beat!
March 11, 2020 -1.13 / -1.06 8.82M / 2.06M Beat!
November 7, 2019 -0.74 / -0.77 2.51M / 2.66M
August 7, 2019 -1.69 / -1.6 3.36M / 3.06M Beat!
May 2, 2019 -2.2 / -2.13 3.98M / 4.42M
Date Price Open High Low Vol Change
Nov 20 8.07 8
8.15
7.76
3.2M 0.88%
Nov 19 8 7.8
8.1
7.65
4.3M 2.17%
Nov 18 7.83 7.41
8.01
7.37
6.9M 6.97%
Nov 15 7.32 7.14
7.33
6.81
9.3M 1.39%
Nov 14 7.22 7.8
7.94
7.17
9.0M -6.96%
 
Nov 13 7.76 8.44
8.56
7.76
7.4M -8.27%
Nov 12 8.46 8.05
8.9
7.89
10.8M -6.1%
Nov 11 9.01 9.89
10.39
8.9
14.7M 1.12%
Nov 8 8.91 9.25
9.25
8.84
3.8M -2.94%
Nov 7 9.18 9.16
9.34
8.99
3.1M 2.46%
Nov 6 8.96 9.06
9.27
8.43
6.5M -5.08%
Nov 5 9.44 9
9.48
8.86
3.5M 3.51%
Nov 4 9.12 9.2
9.3
8.9
4.3M -2.46%
Nov 1 9.35 9.69
9.87
9.29
4.4M -2.71%
Oct 31 9.61 9.83
9.9
9.51
3.6M -2.34%
Oct 30 9.84 10
10.07
9.7
4.0M -2.28%
Oct 29 10.07 10.24
10.63
9.88
4.5M -1.76%
Oct 28 10.25 9.9
10.48
9.73
5.1M 5.24%
Oct 25 9.74 9.9
9.92
9.52
5.0M -1.81%
Oct 24 9.92 10
10.15
9.85
3.5M -0.8%
Oct 23 10 10.1
10.24
9.92
3.4M -1.19%
Oct 22 10.12 10.14
10.35
10.01
3.5M -0.2%
Oct 21 10.14 10.1
10.22
9.9
4.8M -0.39%
Oct 18 10.18 10.4
10.8
10.1
7.1M -1.64%
Oct 17 10.35 10.16
10.41
9.87
9.9M 1.97%
Oct 16 10.15 10.43
10.67
9.62
32.3M -19.44%
Oct 15 12.6 12.67
12.86
12.38
3.3M -0.16%
Oct 14 12.62 12.43
13.34
12.23
5.6M 0.72%
Oct 11 12.53 12.72
13.04
12.34
5.8M -2.87%
Oct 10 12.9 12.6
13.33
12.6
4.5M 1.74%
Oct 9 12.68 13.17
13.35
12.6
6.1M -2.76%
Oct 8 13.04 12.98
13.61
12.94
3.5M 0.15%
Oct 7 13.02 13.72
13.77
12.82
4.6M -4.34%
Oct 4 13.61 14.46
14.7
13.18
7.5M -5.62%
Oct 3 14.42 14.07
15.09
14.01
7.0M -1.77%
Oct 2 14.68 12.32
15.22
12.18
17.5M 19.16%
Oct 1 12.32 12.6
12.66
11.71
6.4M -2.45%
Sep 30 12.63 13.21
13.45
12.61
4.1M -5.04%
Sep 27 13.3 12.32
13.48
12.15
7.0M 9.47%
Sep 26 12.15 12.27
12.46
11.95
3.9M 0.91%
Sep 25 12.04 13.66
14.17
11.9
11.7M -9.41%
Sep 24 13.29 12.86
13.68
12.62
6.6M 3.83%
Sep 23 12.8 13.01
13.3
12.69
4.0M -0.85%
Sep 20 12.91 12.52
13.36
12.34
8.9M 3.12%
Sep 19 12.52 12.79
13.13
12.35
5.0M -0.32%
Sep 18 12.56 12.95
13.38
12.42
5.7M -2.86%
Sep 17 12.93 13.32
13.9
12.7
6.2M -2.05%
Sep 16 13.2 13.61
13.83
13.1
5.6M -3.01%
Sep 13 13.61 11.87
14.03
11.82
12.2M 14.18%
Sep 12 11.92 11.75
12.17
11.09
5.8M -3.01%
Sep 11 12.29 12.7
12.91
11.98
4.8M -3.23%
Sep 10 12.7 12.75
12.89
12.24
3.2M -0.63%
Sep 9 12.78 11.76
12.84
11.71
5.4M 9.89%
Sep 6 11.63 11.91
12.12
11.43
2.8M -2.68%
Sep 5 11.95 11.86
12.1
11.26
3.8M 0.67%
Sep 4 11.87 12.58
13.84
11.64
12.2M -6.31%
Sep 3 12.67 12.29
13.2
12.26
8.6M 2.34%
Aug 30 12.38 11.45
12.48
11.13
9.8M 8.60%
Aug 29 11.4 11.16
11.62
10.93
2.6M 2.43%
Aug 28 11.13 11.12
11.34
10.94
2.7M 0%